CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. Read more about CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
Determinants of the rate of nicotine metabolism and effects on smoking behavior. Read more about Determinants of the rate of nicotine metabolism and effects on smoking behavior.
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Read more about Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
Female sex and oral contraceptive use accelerate nicotine metabolism. Read more about Female sex and oral contraceptive use accelerate nicotine metabolism.
Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests. Read more about Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.
Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation. Read more about Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation.
Short-term metabolic and hemodynamic effects of ephedra and guarana combinations. Read more about Short-term metabolic and hemodynamic effects of ephedra and guarana combinations.
Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine. Read more about Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine.
Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Read more about Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.
Enhanced stimulant and metabolic effects of combined ephedrine and caffeine. Read more about Enhanced stimulant and metabolic effects of combined ephedrine and caffeine.
